Evexia Lifecare Q2 FY27 Results (BSE: 524444)
Signal: Revenue declined
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹25.02 Cr | -2.75% | -19.02% |
| Net profit | ₹0.23 Cr | -37.89% | |
| EPS | ₹0 | -50.0% | |
| EBIT margin | 2.92% |
P&L walk
Consolidated revenue from operations declined 2.75% YoY to ₹2,501.84 lakh, but gross margin expanded 948bps to 12.32%; EBITDA rose 36.23% to ₹72.98 lakh, yet PAT fell 37.89% to ₹23.10 lakh because the profit line includes a ₹4.82 lakh loss attributable to non-controlling interests and EPS was diluted.
Research and educational content only. Not investment advice.